Amphetamine-Related Disorders
Information
- Disease name
- Amphetamine-Related Disorders
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00000322 | Completed | Phase 2 | Tyrosine for Methamphetamine Dependence - 1 | April 1997 | December 2001 |
| NCT00248092 | Completed | Phase 1/Phase 2 | Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse | January 2006 | May 2006 |
| NCT00254306 | Completed | Functional Brain Imaging in Recreational Users of Ecstasy | January 2006 | July 2011 | |
| NCT00856323 | Completed | Phase 2 | Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men | January 2009 | December 2010 |
| NCT00886886 | Completed | Phase 1 | Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK) | April 2009 | March 2010 |
| NCT00895804 | Completed | Phase 1 | Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine) | June 2001 | March 2002 |
| NCT00990067 | Completed | Phase 1 | Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) | November 2009 | May 2010 |
| NCT01136278 | Completed | Phase 1 | Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA) | July 2010 | December 2010 |
| NCT01270672 | Completed | N/A | Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA) | January 2011 | May 2011 |
| NCT01296802 | Completed | N/A | Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging | April 2006 | July 2008 |
| NCT01386177 | Completed | Phase 1 | Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA) | July 2011 | January 2012 |
| NCT01449565 | Completed | Phase 2 | Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) | September 2012 | March 2016 |
| NCT01888835 | Completed | Phase 2 | Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0) | August 2013 | October 2017 |
| NCT02232789 | Completed | Phase 1 | Abuse Liability and Human Pharmacology of Mephedrone | September 2014 | December 2014 |
| NCT02294266 | Completed | Phase 1 | Mephedrone and Alcohol Interactions in Humans | December 2014 | March 2015 |
| NCT02797990 | Completed | Conflict Between Maternal Autonomy and Child Health in Substance-use | May 2016 | September 2016 | |
| NCT00040053 | Completed | Phase 2 | Ondansetron for the Treatment of Methamphetamine Dependence - 1 | June 2002 | February 2004 |
| NCT00069251 | Completed | Phase 2 | Bupropion for the Treatment of Methamphetamine Dependence - 1 | July 2003 | June 2005 |
| NCT00158197 | Completed | N/A | Long-term Behavior Change - 1 | December 2004 | June 2008 |
| NCT00247572 | Completed | Phase 2 | Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories | September 2005 | November 2005 |
| NCT05515757 | Enrolling by invitation | N/A | Hospital-Based Contingency Management | August 22, 2022 | December 2024 |
| NCT04982796 | Recruiting | Phase 1/Phase 2 | Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder | July 7, 2022 | April 30, 2025 |
| NCT06145698 | Recruiting | N/A | Treatment Effect of Cross-frequency Transcranial Alternating Current Stimulation on the MUD | October 15, 2023 | February 15, 2024 |
| NCT00033072 | Unknown status | Phase 1 | Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1 | September 2001 | October 2002 |
| NCT00040040 | Unknown status | Phase 1 | Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1 | June 2002 | September 2003 |
| NCT00089440 | Unknown status | Phase 1 | Assessment of Interactions Between Methamphetamine and Aripiprazole - 1 | June 2004 | March 2005 |
| NCT00100074 | Unknown status | Phase 1 | To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1 | September 2004 | April 2005 |
| NCT03902405 | Unknown status | N/A | Computerized Exercise to Alter Stimulant Approach Responses | June 11, 2018 | March 31, 2022 |
| NCT04203654 | Unknown status | N/A | Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment Model | February 24, 2020 | December 15, 2020 |
| NCT01899313 | Unknown status | N/A | A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence | May 2014 | |
| NCT00265278 | Unknown status | Phase 1 | Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1 | March 2005 | March 2006 |
| NCT00000346 | Unknown status | Phase 4 | Cognitive Correlates of Substance Abuse - 11 | ||
| NCT00267657 | Unknown status | Phase 1 | A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1 | January 2004 | November 2004 |
| NCT00000350 | Unknown status | Phase 1 | Effects of Stimulant Dependence on Human Striatal Dopamine System - 15 | March 1999 | |
| NCT00000351 | Unknown status | Cognitive Correlates of Substance Abuse, Part 2 - 16 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D019969